Aurobindo Pharma has received approval from the US Food and Drug Administration (FDA) for its anti-bacterial drug Daptomycin.
Dubash Radhika has now acquired 78,000 equity shares of the company at Rs 26.4 per share on the NSE.
Foreign investors with a high rate of interest in the lender are expected to regain interest after the country’s largest private lender is no longer on the FPI red flag list.
The IT major has partnered with South America’s leading airline Avianca to accelerate its journey from a non-cloud, analogue world to a cloud-based digital world.
The smallcap pharma company has acquired a 100% stake in Akshar Jyot (AJPL). AJPL will acquire a 26% stake in Dhari Chemicals. The process is underway.